These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12446047)

  • 1. Design, synthesis and evaluation of peptide libraries as potential anti-HIV compounds, via inhibition of gp120/cell membrane interactions, using the gp120/cd4/fab17 crystal structure.
    Boussard C; Doyle VE; Mahmood N; Klimkait T; Pritchard M; Gilbert IH
    Eur J Med Chem; 2002 Nov; 37(11):883-90. PubMed ID: 12446047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and evaluation of potential inhibitors of HIV gp120-CD4 interactions.
    Boussard C; Klimkait T; Mahmood N; Pritchard M; Gilbert IH
    Bioorg Med Chem Lett; 2004 May; 14(10):2673-6. PubMed ID: 15109676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short peptides with induced beta-turn inhibit the interaction between HIV-1 gp120 and CD4.
    Choi YH; Rho WS; Kim ND; Park SJ; Shin DH; Kim JW; Im SH; Won HS; Lee CW; Chae CB; Sung YC
    J Med Chem; 2001 Apr; 44(9):1356-63. PubMed ID: 11311058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage randomization in a charybdotoxin scaffold leads to CD4-mimetic recognition motifs that bind HIV-1 envelope through non-aromatic sequences.
    Li C; Dowd CS; Zhang W; Chaiken IM
    J Pept Res; 2001 Jun; 57(6):507-18. PubMed ID: 11437954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular docking guided structure based design of symmetrical N,N'-disubstituted urea/thiourea as HIV-1 gp120-CD4 binding inhibitors.
    Sivan SK; Vangala R; Manga V
    Bioorg Med Chem; 2013 Aug; 21(15):4591-9. PubMed ID: 23777826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships in the binding of chemically derivatized CD4 to gp120 from human immunodeficiency virus.
    Xie H; Ng D; Savinov SN; Dey B; Kwong PD; Wyatt R; Smith AB; Hendrickson WA
    J Med Chem; 2007 Oct; 50(20):4898-908. PubMed ID: 17803292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design of peptides that recognize the CD4 binding domain of HIV-1 gp120.
    Fontenot JD; Tan X; Phillips DM
    AIDS; 1998 Aug; 12(12):1413-8. PubMed ID: 9727561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV coreceptors: role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitors.
    Zaitseva M; Peden K; Golding H
    Biochim Biophys Acta; 2003 Jul; 1614(1):51-61. PubMed ID: 12873765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV gp120: double lock strategy foils host defences.
    Sattentau QJ
    Structure; 1998 Aug; 6(8):945-9. PubMed ID: 9739096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding to CD4 of synthetic peptides patterned on the principal neutralizing domain of the HIV-1 envelope protein.
    Autiero M; Abrescia P; Dettin M; Di Bello C; Guardiola J
    Virology; 1991 Dec; 185(2):820-8. PubMed ID: 1720590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Aminothiazolones as anti-HIV agents that act as gp120-CD4 inhibitors.
    Tiberi M; Tintori C; Ceresola ER; Fazi R; Zamperini C; Calandro P; Franchi L; Selvaraj M; Botta L; Sampaolo M; Saita D; Ferrarese R; Clementi M; Canducci F; Botta M
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3043-52. PubMed ID: 24614386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C4 region as a target for HIV entry inhibitors--NMR mapping of the interacting segments of T20 and gp120.
    Moseri A; Biron Z; Arshava B; Scherf T; Naider F; Anglister J
    FEBS J; 2015 Dec; 282(24):4643-57. PubMed ID: 26432362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of potential anti-HIV GP120 inhibitors using a lysine template.
    Doyl VE; Klimkait T; Mahmood N; Slater M; Hazen RJ; Gilbert IH
    J Enzyme Inhib Med Chem; 2002 Jun; 17(3):175-82. PubMed ID: 12443043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional, discontinuous HIV-1 gp120 C3/C4 domain-derived, branched, synthetic peptide that binds to CD4 and inhibits MIP-1alpha chemokine binding.
    Howie SE; Fernandes ML; Heslop I; Hewson TJ; Cotton GJ; Moore MJ; Innes D; Ramage R; Harrison DJ
    FASEB J; 1999 Mar; 13(3):503-11. PubMed ID: 10064617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E-pharmacophore based screening to identify potential HIV-1 gp120 and CD4 interaction blockers for wild and mutant types.
    Chandra I; Prabhu SV; Nayak C; Singh SK
    SAR QSAR Environ Res; 2021 May; 32(5):353-377. PubMed ID: 33832362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural determinants for affinity enhancement of a dual antagonist peptide entry inhibitor of human immunodeficiency virus type-1.
    Gopi H; Umashankara M; Pirrone V; LaLonde J; Madani N; Tuzer F; Baxter S; Zentner I; Cocklin S; Jawanda N; Miller SR; Schön A; Klein JC; Freire E; Krebs FC; Smith AB; Sodroski J; Chaiken I
    J Med Chem; 2008 May; 51(9):2638-47. PubMed ID: 18402432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
    Barbouche R; Decroly E; Kieny MP; Fenouillet E
    Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Virtual screening of small molecular HIV-1 entry inhibitor NC-2 targeting gp120 and its action mechanism].
    Duan H; Wang Y; Song D; Chen Z; Qiu J; Lu L; Jiang S; Liu S; Tan S
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):826-31. PubMed ID: 23803191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of novel piperazine derivatives as CCR5 antagonists.
    Liu T; Weng Z; Dong X; Chen L; Ma L; Cen S; Zhou N; Hu Y
    PLoS One; 2013; 8(1):e53636. PubMed ID: 23308267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.